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GeBACKGROUND It is not known whether high-risk plaque, as detected by coronary computed tomography angiography
(CTA), permits improved early diagnosis of acute coronary syndromes (ACS) independently to the presence of signiﬁcant
coronary artery disease (CAD) in patients with acute chest pain.
OBJECTIVES The primary aim of this study was to determine whether high-risk plaque features, as detected by CTA in
the emergency department (ED), may improve diagnostic certainty of ACS independently and incrementally to the
presence of signiﬁcant CAD and clinical risk assessment in patients with acute chest pain but without objective evidence
of myocardial ischemia or myocardial infarction (MI).
METHODS We included patients randomized to the coronary CTA arm of the ROMICAT-II (Rule Out Myocardial Infarction/
Ischemia Using Computer-Assisted Tomography II) trial. Readers assessed coronary CTA qualitatively for the presence of
nonobstructive CAD (1% to 49% stenosis), signiﬁcant CAD ($50% or $70% stenosis), and the presence of at least 1 of
the high-risk plaque features (positive remodeling, low <30 Hounsﬁeld units plaque, napkin-ring sign, spotty calcium). In
logistic regression analysis, we determined the association of high-risk plaque with ACS (MI or unstable angina pectoris)
during the index hospitalization and whether this was independent of signiﬁcant CAD and clinical risk assessment.
RESULTS Overall, 37 of 472 patients who underwent coronary CTA with diagnostic image quality (mean age 53.9  8.0
years; 52.8% men) had ACS (7.8%; MI n ¼ 5; unstable angina pectoris n ¼ 32). CAD was present in 262 patients (55.5%;
nonobstructive CAD in 217 patients [46.0%] and signiﬁcant CAD with $50% stenosis in 45 patients [9.5%]). High-risk
plaques were more frequent in patients with ACS and remained a signiﬁcant predictor of ACS (odds ratio [OR]: 8.9; 95%
CI: 1.8 to 43.3; p ¼ 0.006) after adjustment for $50% stenosis (OR: 38.6; 95% CI: 14.2 to 104.7; p < 0.001) and clinical
risk assessment (age, sex, number of cardiovascular risk factors). Similar results were observed after adjustment
for $70% stenosis.
CONCLUSIONS In patients presenting to the ED with acute chest pain but negative initial electrocardiogram and
troponin, presence of high-risk plaques on coronary CTA increased the likelihood of ACS independent of signiﬁcant
CAD and clinical risk assessment (age, sex, and number of cardiovascular risk factors). (Multicenter Study to Rule
Out Myocardial Infarction by Cardiac Computed Tomography [ROMICAT-II]; NCT01084239) (J Am Coll Cardiol
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685ABB R E V I A T I O N S
AND ACRONYMS
ACS = acute coronary
syndromes
CAD = coronary artery disease
CTA = computed tomography
angiography
ED = emergency department
HU = Hounsﬁeld units
MI = myocardial infarctionC oronary computed tomography angiography(CTA) is a viable alternative to functionaltesting with or without imaging in the eval-
uation of patients with acute chest pain in the emer-
gency department (ED) (1–3). However, the related
trials revealed uncertainty around management deci-
sions in patients with signiﬁcant coronary artery dis-
ease (CAD) by CTA because the positive predictive
value of CTA for signiﬁcant CAD remains moderate.
Furthermore, the ROMICAT-I (Rule Out Myocardial
Infarction/Ischemia Using Computer-Assisted To-
mography I) trial demonstrated that the presence
of stenosis >50% had limited diagnostic value for
acute coronary syndromes (ACS) because only 46%
of patients who had obstructive CAD by CTA had
matching single-photon emission computed tomogra-
phy (SPECT) perfusion abnormalities during stress
testing (4). Therefore, the optimal management of
patients with signiﬁcant CAD on CTA in this setting
remains uncertain.SEE PAGE 693An opportunity for more efﬁcient use of CTA in the
management of patients with chest pain may arise
from the ability of CTA to accurately assess plaque
characteristics, such as positive remodeling, spotty
calcium, low Hounsﬁeld units (HU) attenuation, and
napkin-ring sign (5–11). Similar characteristics have
been demonstrated to represent high-risk plaque on
histology (necrotic lipid-rich core, thin-cap ﬁbroather-
oma, positive remodeling, spotty calcium) (12,13) and
intravascular imaging (positive remodeling, larger
plaque volume, spotty calcium) (14,15). Furthermore,
initial evidence from CTA studies has suggested that
these features were associated with an increased risk
for future cardiovascular events in patients with
stable chest pain syndromes (16–18) However, there
are limited data on the potential use of high-risk pla-
que on CTA in patients with acute chest pain (19,20).
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ACS independently and incrementally to the
presence of signiﬁcant CAD and clinical risk
assessment in patients with acute chest pain
but without objective evidence of myocardial
ischemia or myocardial infarction (MI).
METHODS
The study cohort consisted of patients who
were randomized to the CTA arm of the
ROMICAT-II trial and underwent CTA (Fig. 1). A
detailed description of the patient population was
reported (2). Between April 2010 and January 2012,
1,000 patients with chest pain, a clinical suspicion for
ACS, and cardiovascular risk factors presenting to the
ED of 9 U.S. hospitals were enrolled. All study par-
ticipants provided written consent for participation
in the ROMICAT-II trial. The local institutional review
boards approved the study.
CTA images were acquired using either retro-
spectively electrocardiogram (ECG)-gated or prospec-
tively ECG-triggered protocols. The investigators
in the study used the scanners from 3 vendors
(Siemens Healthcare, Erlangen, Germany; GE Health-
care, Waukesha, Wisconsin; or Toshiba America
Medical Systems, Tustin, California) and different
scanner generations (64, 128, and 256 row and dual
source). The images were transferred to the core lab-
oratory. Image analysis was performed on a cardiac
workstation (TeraRecon, Foster City, California).
Three readers with at least 5 years of experience and
level III training in CTA analyzed the datasets. Each
reader analyzed one-third of randomly assigned
CTA datasets. Further, 30 randomly selected CTA
datasets were analyzed by all 3 readers to determine
interobserver agreement. The CTA analysis was per-
formed per coronary segment using the model of the
Society of Cardiovascular Computed Tomography (21).
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ROMICAT-II trial
(n = 1,000)
ROMICAT-II CTA arm
(n = 501)
Excluded:
- 499 patients in standard of care arm
Excluded:
- 28 patients not undergoing CTA
- 1 patient due to nondiagnostic image quality
Study population
(n = 472)
FIGURE 1 Study Population Enrollment, Exclusion, and Inclusion
The ﬂow chart summarizes the selection of the patient population included in
the analysis. CTA ¼ computed tomography angiography; ROMICAT-II ¼ Rule
Out Myocardial Infarction/Ischemia Using Computer-Assisted Tomography II.
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686for the presence of stenosis and coronary plaque with
conﬁdence. Coronary segments that were assessed
as nondiagnostic in image quality were treated as
noninformative for the purpose of the analysis.
Each evaluable coronary segment was assessed
for the presence of stenosis. The severity of stenosis
was quantiﬁed by visual estimation and divided into 4
categories: 0% no stenosis, 1% to 49% mild stenosis,
50% to 70% moderate stenosis, and $70% severe
stenosis/occlusion. For each evaluable coronary seg-
ment, we noted the presence of plaque. Noncalciﬁed
coronary plaque was deﬁned as any discernible
structure that could be assigned to the coronary artery
wall, had a CT number below the contrast-enhanced
coronary lumen but above the surrounding connec-
tive tissue, and could be identiﬁed in at least 2 inde-
pendent planes (22). Any structure with a density
of $130 HU that could be visualized separately from
the contrast-enhanced coronary lumen, assigned to
the coronary artery wall, and identiﬁed in at least
2 independent planes was deﬁned as calciﬁed ath-
erosclerotic plaque (22). In each coronary segment
with plaque, we performed further qualitative evalu-
ation for the presence of high-risk plaque features,
which were deﬁned as positive remodeling, low
CT number of plaque, napkin-ring sign, and spotty
calcium (Central Illustration). Positive remodeling
was assessed visually in multiplanar reformatted im-
ages reconstructed in long-axis and short-axis views
of the vessel. Additional manual measurements of
outer vessel diameter were performed at the readers’
discretion, and a threshold of 1.1 was used to deﬁne
positive remodeling (5,6). If low CT attenuation
was visually noted in noncalciﬁed plaque, readers
placed 3 random region-of-interest measurements(approximately 0.5 to 1.0 mm2) in the noncalciﬁed low
CT attenuation portion of the plaque. Low HU plaque
was deﬁned as the mean CT number within these
3 regions of interest <30 HU (7,16). The napkin-ring
sign was deﬁned as a ring-like peripheral higher
attenuation of the noncalciﬁed portion of the coro-
nary plaque (20,23–25). Spotty calcium was deﬁned
as the presence of calciﬁed plaque with a diameter
<3 mm in any direction, length (extent in the longi-
tudinal direction of the vessel) of the calcium less
than 1.5 times the vessel diameter, and width (extent
of the calciﬁcation perpendicular to the longitudinal
direction of the vessel) of the calciﬁcation less than
two-thirds of the vessel diameter (8,9,26). The pa-
tient was classiﬁed as having high-risk plaque fea-
tures if at least 1 high-risk plaque feature was
present.
The primary outcome of the study was an ACS
event during the index hospitalization. ACS was
deﬁned as acute MI or unstable angina pectoris ac-
cording to the American College of Cardiology/
American Heart Association Guidelines (2,27). An in-
dependent clinical events committee predeﬁned and
adjudicated the endpoint. We excluded ACS (MI)
during the index hospitalization in a patient with
an anomalous right coronary artery from the main
pulmonary artery, but with no evidence of coro-
nary plaque or stenosis, who underwent reimplanta-
tion of the right coronary artery during the index
hospitalization.
All statistical analyses were performed using
Stata 13.1 (StataCorp LP, College Station, Texas).
Continuous data are presented as mean  SD.
Comparisons between groups were performed with
the use of an independent sample Student t test for
continuous variables, Fisher exact test for categori-
cal variables, and Wilcoxon rank-sum test for
ordinal variables. To determine whether the pres-
ence of high-risk plaque was an independent pre-
dictor of ACS, we performed multivariable logistic
regression analyses and adjusted for the presence
of $50% stenosis, age, sex, and the number of
cardiovascular risk factors (hypertension, dyslipide-
mia, diabetes mellitus, smoking status, and family
history of premature CAD). We also performed the
analyses with a definition of signiﬁcant CAD as $70%
stenosis or left main coronary stenosis $50%. To
determine whether high-risk plaque was incremental
to the presence of signiﬁcant CAD and clinical risk
assessment, we compared areas under the receiver-
operating characteristics curve (AUC) using the
DeLong algorithm (28). For all analyses, a 2-tailed
p value <0.05 was required to reject the null
hypothesis.
CENTRAL ILLUSTRATION Signiﬁcant Stenosis and High-Risk Coronary Plaque
Features and Their Association With the Probability of ACS During Index
Hospitalization
Stenosis $50%: severe stenosis of the mid left anterior descending coronary artery
(red arrow). Positive remodeling: Noncalciﬁed plaque with positive remodeling in the
distal right coronary artery. The 2 dotted red lines demonstrate the vessel diameters at
the proximal and distal references (both 1.8 mm), and the solid red line demonstrates the
maximal vessel diameter in the mid portion of the plaque (2.7 mm). The remodeling index
is 1.5. Low Hounsﬁeld units (HU) plaque: partially calciﬁed plaque in the mid right coronary
artery with low <30 HU plaque. The red circles demonstrate the 3 regions of interest, with
mean computed tomography (CT) numbers of 22 HU, 19 HU, and 20 HU. Napkin-ring sign:
napkin-ring sign plaque in the mid left anterior descending coronary artery. Schematic
cross-sectional view of the napkin-ring sign. The red line demonstrates the central low HU
area of the plaque adjacent to the lumen (yellow ellipse) surrounded by a peripheral rim of
the higher CT attenuation (red arrows). Spotty calcium: partially calciﬁed plaque in the
mid right coronary artery with spotty calciﬁcation (diameter <3 mm in all directions;
red circles). ACS ¼ acute coronary syndromes; RR ¼ relative risk.
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687RESULTS
From 501 patients randomized to CTA, 473 underwent
CTA. Reasons for not undergoing CTA were patient
declined CTA (n ¼ 9), safety concerns (n ¼ 5), un-
availability of CTA (n ¼ 5), and technical difﬁculties
(n ¼ 9). One patient was excluded from further
analysis due to nondiagnostic image quality in all
coronary segments. CTA was performed using the
scanners from 3 vendors (Siemens 58%, GE 34%,
Toshiba 7%). Overall, 472 patients who underwent
CTA with diagnostic image quality formed the
study population (mean age 53.9  8.0 years;
52.8% men). The prevalence of ACS was 7.8% (n ¼ 37;
MI n ¼ 5; unstable angina pectoris n ¼ 32). Patients
with ACS had more cardiovascular risk factors and
higher Thrombolysis in Myocardial Infarction scores
(Table 1).
Overall, 202 of 6,855 coronary segments (2.9%)
were nonevaluable, with at least 1 nonevaluable
segment present in 71 of 472 patients (15.0%). The
most common reason for nonevaluability was the
presence of motion artifacts (n ¼ 153), followed by
coronary calcium (n ¼ 31) and poor contrast-to-noise
ratio (n ¼ 17). Interobserver agreement among 3
readers in 30 patients was very good for the presence
of coronary plaque (kappa ¼ 0.77) and signiﬁcant
CAD (stenosis $50%; kappa ¼ 0.80) and good for
high-risk plaque (kappa ¼ 0.69).
CAD, deﬁned as the presence of any plaque, was
detected in 262 patients (55.5%). Among 262 patients
with coronary plaque, calciﬁed plaques were pre-
sent in 217 (82.2%) and noncalciﬁed plaques in
199 (76.0%) patients. Nonobstructive CAD (1% to
49% stenosis) was detected in 217 of 472 patients
(46.0%). Signiﬁcant CAD ($50% stenosis) was found
in 45 of 472 patients (9.5%). Stenosis $70% or left
main coronary stenosis $50% was detected in 24
patients (5.1%).
At least 1 high-risk plaque feature was present
in 167 of 472 patients (35.4%), at least 2 high-
risk plaque features were present in 56 patients
(11.9%), and at least 3 high-risk plaque features
were present in 35 patients (7.4%). The most com-
mon feature was spotty calcium (n ¼ 151 [32.0%])
followed by positive remodeling (n ¼ 55 [11.7%]),
low HU plaque (n ¼ 40 [8.5%]), and napkin-ring
sign (n ¼ 26 [5.5%]).
Among 45 patients with signiﬁcant CAD ($50%
stenosis), at least 1, 2, and 3 or more high-risk plaque
features were present in 41 (91.1%), 27 (60.0%), and
24 (53.3%) patients, respectively. The prevalence of
the individual high-risk plaque features in patients
with signiﬁcant CAD was as follows: spotty calcium in40 (88.9%), positive remodeling in 28 (62.2%), low HU
plaque in 19 (42.2%), and napkin-ring sign in
16 (35.6%) patients. We observed a lower prevalence
of high-risk plaque features in 217 patients with
nonobstructive CAD (1% to 49% stenosis). At least 1, 2,
and 3 high-risk plaque features were present in 125
(57.6%), 29 (13.4%), and 11 (5.1%) patients, respec-
tively. The prevalence of the individual high-risk
plaque features in patients with nonobstructive CAD
was as follows: spotty calcium in 111 (51.2%), positive
TABLE 1 Clinical Characteristics of Study Patients Stratiﬁed According to the
Diagnosis of ACS
ACS
(n ¼ 37)
No ACS
(n ¼ 435) p Value
Age, yrs 57.2  8.3 53.6  7.9 0.015
Women 6 (16.2) 217 (49.9) <0.001
Cardiovascular risk factors
Hypertension 22 (59.5) 230 (52.9) 0.50
Diabetes mellitus 7 (18.9) 72 (16.6) 0.65
Dyslipidemia 25 (67.6) 191 (43.9) 0.006
Former or current smoker 25 (67.6) 211 (48.5) 0.039
Family history of premature CAD 11 (29.7) 120 (27.6) 0.85
Number of cardiovascular risk factors 0.005
0 or 1 21.6 37.5
2 or 3 62.2 53.6
$4 16.2 9.0
TIMI score <0.001
0 35.1 63.9
1 46.0 27.1
2 18.9 8.1
3 0.0 0.9
Troponin classiﬁcation <0.001
Negative 28 (75.7) 426 (97.9)
Borderline 6 (16.2) 8 (1.9)
Elevated 3 (8.1) 1 (0.2)
Invasive coronary angiography 32 (86.5) 19 (4.4) <0.001
Signiﬁcant CAD ($50% stenosis)
in angiography
31 (96.9) 5 (26.3) <0.001
Percutaneous coronary intervention 22 (59.5) 0 (0.0) <0.001
Coronary artery bypass graft surgery 4 (10.8) 1 (0.2) <0.001
Values are mean  SD, n (%), or %.
ACS ¼ acute coronary syndromes; CAD ¼ coronary artery disease; TIMI ¼ Thrombolysis in
Myocardial Infarction.
Puchner et al. J A C C V O L . 6 4 , N O . 7 , 2 0 1 4
High-Risk Plaque on CTA Predicts ACS A U G U S T 1 9 , 2 0 1 4 : 6 8 4 – 9 2
688remodeling in 27 (12.4%), low HU plaque in 21 (9.7%),
and napkin-ring sign in 10 (4.6%) patients.
A comparison of the CTA ﬁndings in patients with
and without ACS is provided in Table 2. All patients
with ACS had evidence of CAD (i.e., either coronary
plaque with 1% to 49% stenosis or $50% stenosis). In
the non-ACS group, almost half of the patients had
no evidence of CAD (p < 0.001). More than 75% of
patients with ACS had signiﬁcant CAD with $50%
stenosis as compared with <4% of patients without
ACS (p < 0.001).
At least 1 high-risk plaque feature was present in
95% of patients with ACS and in 30% of patients
without ACS (p < 0.001). All individual high-risk
plaque features were more often observed in pa-
tients with ACS (p < 0.001). Furthermore, all patients
with ACS and without $50% stenosis had at least 1
high-risk plaque.
The presence of ACS was strongly associated
with the presence of signiﬁcant CAD ($50% steno-
sis) as detected by coronary CTA. In univariateanalysis, patients with signiﬁcant CAD ($50% ste-
nosis) were 34 times more likely to have ACS during
the index hospitalization as compared with those
without signiﬁcant CAD (Fig. 2). Similar to signiﬁ-
cant CAD, the presence of any high-risk plaque
was associated with ACS. Patients with at least
1 high-risk plaque feature were 32 times more likely
to have ACS during the index hospitalization. All
individual high-risk plaque features were associated
with ACS.
In the logistic regression analysis (Table 3),
the presence of high-risk plaque (odds ratio [OR]:
8.9; 95% conﬁdence interval [CI]: 1.8 to 43.3; p ¼
0.006) remained signiﬁcantly associated with ACS
after adjustment for $50% stenosis (OR: 38.6; 95%
CI: 14.2 to 104.7; p < 0.001) and clinical predictors
(age: OR: 1.0, 95% CI: 0.9 to 1.1, p ¼ 0.87; female:
OR: 0.4, 95% CI: 0.1 to 1.2, p ¼ 0.104; number of
cardiovascular risk factors: OR: 1.3, 95% CI: 0.8 to
2.0, p ¼ 0.278). Similar results were observed when
signiﬁcant CAD was deﬁned as stenosis $70% or left
main coronary stenosis $50%.
We demonstrated that coronary stenosis $50%
was incremental to baseline clinical characteristics
(age, sex, number of cardiovascular risk factors) in
predicting ACS (model 2: AUC 0.935; 95% CI: 0.894
to 0.976 vs. model 1: AUC 0.776; 95% CI: 0.711
to 0.840; p < 0.001). We observed that adding
the presence of high-risk plaque to the model
further improved the prediction of ACS (model 3:
AUC 0.959, 95% CI: 0.937 to 0.981 vs. model 1,
p < 0.001; model 3 vs. model 2, p ¼ 0.03). Similar
results were observed when signiﬁcant CAD was
deﬁned as stenosis $70% or left main coronary
stenosis $50%.
DISCUSSION
We demonstrated that high-risk coronary plaque as
detected on CTA in patients presenting to the ED
with acute chest pain was associated with ACS
independently and incrementally to the presence of
signiﬁcant CAD and clinical risk assessment. Our
results suggested that CTA-based assessment of
high-risk plaque improved diagnosis of ACS in
patients with acute chest pain who otherwise
had no ECG or enzymatic evidence of ischemia or
infarction.
Our understanding of morphological features of
high-risk plaque stems primarily from the histology
studies of patients who died of sudden cardiac
death. The histological features of the culprit pla-
ques included large necrotic core, higher macro-
phage count, positive remodeling, speckled calcium,
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FIGURE 2 Probability of ACS During Index Hospitalization According
to CTA Characteristics
The ﬁgure reports the probability of ACS during index hospitalization according to
computed tomography angiography (CTA) assessment for signiﬁcant coronary artery dis-
ease ($50% stenosis) and the presence of high-risk plaque features. ACS ¼ acute coronary
syndromes; Ca ¼ calcium; CI ¼ conﬁdence interval; HU ¼ Hounsﬁeld units; NRS ¼ napkin-
ring sign; PR ¼ positive remodeling.
TABLE 2 Coronary Computed Tomography Angiography
Characteristics of Patients Stratiﬁed According to the
Diagnosis of ACS
ACS
(n ¼ 37)
No ACS
(n ¼ 435) p Value
CAD category
No CAD 0 (0.0) 210 (48.3) <0.001
Nonobstructive CAD
(1% to 49% stenosis)
8 (21.6) 209 (48.1) 0.002
Signiﬁcant CAD ($50%
stenosis)
29 (78.4) 16 (3.7) <0.001
Plaque category
No plaque 0 (0.0) 210 (48.3) <0.001
Calciﬁed plaque 36 (97.3) 181 (41.6) <0.001
Noncalciﬁed plaque 36 (97.3) 163 (37.5) <0.001
High-risk plaque category
Any high-risk plaque 35 (94.6) 132 (30.3) <0.001
Napkin-ring sign 12 (32.4) 14 (3.2) <0.001
Positive remodeling 22 (59.5) 33 (7.6) <0.001
Low HU plaque 16 (43.2) 24 (5.5) <0.001
Spotty calcium 35 (94.6) 116 (26.7) <0.001
Values are n (%).
HU ¼ Hounsﬁeld units; other abbreviations as in Table 1.
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689and thin ﬁbrous cap (12,13). Similar morphological
features (positive remodeling, larger plaque area,
spotty calcium, and large necrotic core) were ob-
served with intravascular imaging in culprit lesions
of ACS (14,15).
The direct comparison of CTA features of high-
risk plaque to virtual histology intravascular ultra-
sound (IVUS-VH) is challenging. In the PROSPECT
(Providing Regional Observations to Study Predictors
of Events in the Coronary Tree) trial, the researchers
demonstrated that lesions associated with recurrent
ACS were characterized by a plaque burden $70%,
by a minimal luminal area #4.0 mm2, or as thin-cap
ﬁbroatheroma (29). CTA characteristics of high-risk
plaque in our study did not exactly correlate to
IVUS-VH measurements. However, the presence of
a minimal luminal area #4.0 mm2 often correlates
with signiﬁcant stenosis, and we demonstrated that
signiﬁcant stenosis was an independent predictor
of ACS. We did not perform quantitative analysis
of plaques, which is necessary for the calculation
of plaque burden. However, there is a correlation
between positive remodeling and large plaque
burden. Finally, the spatial resolution of CTA does
not permit the detection of thin-cap ﬁbroatheroma.
However, the presence of the napkin-ring sign
was very speciﬁc for the presence of advanced
atheroma (23).
High-risk plaque features have been the target of
noninvasive imaging with CTA. An early CTA studyshowed the feasibility of detecting high-risk plaque
(5). The culprit plaques of ACS were often positively
remodeled and had larger plaque burden compared
with similarly stenotic plaques in patients with stable
angina. Subsequent studies extended this observa-
tion and showed an association of plaque features
such as large plaque burden, positive remodeling,
spotty calcium, low HU plaque, and napkin-ring sign
with ACS (7,9,19,20) and with an increased risk of
future cardiovascular events (16-18). Limited data
exist on the role of high-risk plaque for early diag-
nosis of ACS in the acute chest pain population
(19,20).
We found that one-third of the patients with
acute chest pain had high-risk plaque, with spotty
calcium as the most frequent high-risk plaque
feature (32.0%), followed by positive remodeling
(11.7%), low HU plaque (8.5%), and napkin-ring sign
(5.5%). The prevalence of high-risk plaque features
observed in our study in the acute chest pain
population is similar to that of other CTA studies
(5% to 15%) performed in populations of patients
undergoing invasive coronary angiography, in
larger unselected patient populations, and in non-
culprit vessels of patients with ACS (PROSPECT
trial) (8,9,16,20,29). The reported prevalence of
spotty calcium varied more dramatically in the
published data (0% to 43%), most likely as a result
of differences in the deﬁnition of spotty calcium
TABLE 3 Multivariable Logistic Regression Analysis for the Prediction of ACS
Using Clinical Predictors and Coronary CTA Assessment
Model 1* Model 2† Model 3‡
OR
(95% CI) p Value
OR
(95% CI) p Value
OR
(95% CI) p Value
Age 1.1
(1.0–1.1)
0.003 1.0
(1.0–1.1)
0.539 1.0
(0.9–1.1)
0.870
Female 0.2
(0.1–0.4)
<0.001 0.3
(0.1–0.8)
0.020 0.4
(0.1–1.2)
0.104
Number of risk
factors§
1.4
(1.0–1.8)
0.056 1.4
(0.9–2.2)
0.124 1.3
(0.8–2.0)
0.278
Stenosis $50% 71.7
(27.1–189.9)
<0.001 38.6
(14.2–104.7)
<0.001
High-risk plaque 8.9
(1.8–43.3)
0.006
*Clinical predictors were age, sex, and number of cardiovascular risk factors (diabetes mellitus, hypertension,
dyslipidemia, smoking status, and family history of premature CAD). †Clinical predictors were those in model
1 plus stenosis $50%. ‡Clinical predictors were those in model 2 plus high-risk plaque. §Number of risk
factors ¼ number of cardiovascular risk factors (diabetes mellitus, hypertension, dyslipidemia, smoking status,
and family history of premature CAD).
OR ¼ odds ratio; other abbreviations as in Table 1.
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690(9,20). In addition, we observed a prevalence of
coronary atherosclerosis deﬁned as any coronary
plaque in 55.5% of patients, nonobstructive CAD in
46.0% of patients, and signiﬁcant stenosis $50% in
9.5% of patients, mostly consistent with other
single-center and multicenter trials in acute chest
pain (1,3,30). Overall, our results demonstrated that
the prevalence of high-risk plaque and its asso-
ciations with CAD and ACS in the acute chest
pain setting are generalizable to multiple centers
and CT vendors, and they were also in accor-
dance with observations in stable chest pain
syndromes as well as in nonculprit vessels of pati-
ents with ACS undergoing percutaneous coronary
interventions.
The assessment of patients presenting with acute
chest pain, but without objective signs of ischemia
or MI, remains a diagnostic challenge. In patients
who present with acute chest pain, exclusion of a
signiﬁcant coronary stenosis and plaque by CTA has
a high sensitivity and negative predictive value for
ACS and allows early discharge (1–3). However, ACS
cannot be ruled out in a signiﬁcant portion of
patients in whom coronary plaques are present,
reducing the speciﬁcity of CTA. Signiﬁcant coronary
stenosis was detected in approximately 10% and
4% of patients in 2 large multicenter trials,
respectively (1,3). However, ACS or major adverse
cardiovascular events developed in only approxi-
mately 4% and 1% of patients. Conversely, the
sensitivity of $50% stenosis for the detection of
ACS was 77% in the ROMICAT-I trial (30). In the
ROMICAT-II study, we found a very similar result,with $50% stenosis detected in 78% of patients
with ACS. This ﬁnding concurs with those of pre-
vious invasive angiographic studies that observed
an absence of signiﬁcant stenosis in 12% to 14% of
patients with ACS (31,32). The limited diagnostic
accuracy of CTA using the traditional criterion of
signiﬁcant stenosis might increase frequency of
downstream testing and interventions (1–3,33). A
potential means to improve CTA diagnostic accu-
racy is by adding the assessment of high-risk pla-
que to stenosis, which improved the diagnostic
assessment of patients with acute chest pain in the
present study.
The value of high-risk plaque for the diagnosis
of ACS in patients with signiﬁcant stenosis was
demonstrated in the ROMICAT-I trial (19). A score
including positive remodeling, spotty calcium, vol-
ume of low HU plaque, and stenosis length had a
good discriminatory capacity for ACS during index
hospitalization but was limited to only those with
signiﬁcant stenosis on CTA. The addition of high-
risk plaque features showed a potential to reﬁne
the diagnosis of ACS by CTA (19,20). The current
study demonstrated that high-risk plaque features
assessed by a qualitative read of CTA images were
independent and incremental to signiﬁcant ste-
nosis and clinical risk assessment for predicting
ACS during the index hospitalization. Although
stenosis remained the strongest predictor of ACS,
high-risk plaque was associated with a 9-fold in-
crease in the likelihood of ACS after adjustment for
the presence of stenosis $50% and clinical risk
assessment.
The inclusion of high-risk plaque improved the
detection of ACS in patients with mild stenosis (1%
to 49%). All patients with mild stenosis and ACS had
at least 1 high-risk plaque feature. We suggest that
patients with mild stenosis and high-risk plaque
cannot be safely discharged from the ED. Further
evaluation with serial troponins and additional
testing will be necessary. While awaiting further
work-up, providers should consider aggressive
medical therapy (e.g., dual antiplatelet therapy). On
the other side of the spectrum, there are patients
with signiﬁcant stenosis. Patients with signiﬁcant
stenosis on CTA cannot be discharged from the ED
after initial troponin and ECG (1–3). In our study, the
presence of high-risk plaque was incremental to
stenosis for the prediction of ACS. Therefore, pro-
viders should consider aggressive medical therapy
and invasive coronary angiography in patients with
signiﬁcant stenosis and high-risk plaque. In patients
with stenosis, but no high-risk plaque, providers
should consider further work-up to conﬁrm the
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Among patients
presenting with acute chest pain, normal initial cardiac troponin
levels, and no evidence of ischemia on electrocardiogram, coro-
nary computed tomography angiography (CTA) can identify high-
risk coronary atherosclerotic lesions independently associated
with acute coronary syndromes and diagnostic information in-
cremental to the detection of $50% luminal stenosis.
TRANSLATIONAL OUTLOOK: Multicenter randomized tri-
als are needed to determine whether medical therapy and/
or interventions based on CTA characterization of high-risk
plaque improves clinical outcomes in patients with acute
chest pain.
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691signiﬁcance of the stenosis (e.g., stress test or inva-
sive coronary angiography with fractional ﬂow
reserve). However, these strategies have not been
tested in prospectively designed clinical studies, and
further studies are required to include them in
routine clinical practice.
STUDY LIMITATIONS. The low number of ACS
outcomes (n ¼ 37) limited our ability to perform
subanalyses and include additional variables in
the multivariable models. Recent studies have de-
monstrated the additional value of quantita-
tive analysis of plaque by CTA (5,6,20–23); we
performed qualitative assessment of stenosis and
high-risk plaque. The decision to use qualitative
assessment was motivated by the fact that this
approach could be more feasible in routine clinical
practice because it adds minimal time for the
assessment and does not require speciﬁc software
and hardware. We restricted our analysis to the 4
most established high-risk plaque features (positive
remodeling, low HU plaque, napkin-ring sign, and
spotty calcium).
CONCLUSIONS
The presence of high-risk plaque on CTA increases
the likelihood of ACS independent and incremen-
tal to the presence of signiﬁcant CAD and clinicalrisk assessment (age, sex, number of cardiovascular
risk factors) in patients with acute chest pain and
with no objective evidence of myocardial ischemia
or MI.
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